| Project Title | Hydroxyurea Use in Patients with Sickle Cell Anemia |
| Date Posted | Tuesday, January 7, 2020 |
| Project ID | cder_mpl1r_wp071, cder_mpl1r_wp078 |
| Status | Complete |
| Deliverables | |
| Description | The purpose of this request was to characterize hydroxyurea use among members with sickle cell anemia (SCA). Data from January 1, 2000 to September 30, 2015 from 17 Data Partners contributing to the Sentinel Distributed Database (SDD) were included in these reports. This request was distributed on February 28, 2018. This request contains two reports. Report 1 estimated the number patients with SCA, the number of SCA patients who were dispensed hydroxyurea, and the average number of hospitalizations and emergency department visits per person-year among those patients in the SDD. Report 2 examines utilization patterns of hydroxyurea among patients with SCA in the SDD. |
| Medical Product | hydroxyurea |
| Health Outcome | sickle cell anemia use by indication |
| Population / Cohort | All individuals |
| Time Period | January 1, 2000 - September 30, 2015 |
| Assessment Type | Exploratory Analyses |
| Study Type | Modular Program |
| Data Sources | Sentinel Distributed Database (SDD) |
| FDA Center | CDER |
